PipelinePharma Logo

benzyl benzoate Cutaneous ointment 250 mg/g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Ukraine
GMP approvals
EU GMP, PICS
Available for
Licensing with supply, Distribution only, Technology transfer
Manufacturer #20450

Established in 1930, this Manufacturer is a CTD dossier owner and manufacturer based in Kyiv, Ukraine. With a workforce of approximately 1,316 employees, it operates GMP-certified facilities producing a diverse range of products, including tablets, capsules, oral liquids, external liquids, and health foods. As a GMP manufacturer, it holds certifications such as TGA GMP (Australia) and complies with international GMP standards, ensuring adherence to international quality standards. The Manufacturer's products are distributed across over 80 countries and regions worldwide. Its commitment to excellence as a CTD dossier owner and manufacturer and GMP manufacturer solidifies its reputation in the global pharmaceutical market.​

 

Manufacturer usually replies in 8 days

Benzyl benzoate is a medication used to treat scabies and lice. Manufacturers of benzyl benzoate use it as the standalone ingredient in drug formulations as well as in combination with other substances, such as tiabendazole, benzocaine, permethrin, sulfur, and others. Benzyl benzoate suppliers market it in the form of topical creams and ointments. Benzyl benzoate has been in medical use for almost century and is on the World Health Organisation’s list of Essential Medicines that contains the most important drugs recommended for a health system. Benzyl benzoate suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified benzyl benzoate manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.